Catamaran Corp.

Power in the health care sector is moving away from the product and toward the compilation and understanding of data, London-based consultant firm EY contended in a recent report. But data is siloed a

The drug pricing debate has moved in some unexpected directions in the US over the past two years. For the most part, the biopharma industry has been successful in focusing attention on the difference

It has been an active year for pharma M&A, with payer and wholesaler consolidation and continued drug-pricing pressure driving consolidation among pharma companies and generics players. The year 2015

Pharmacy benefit manager Express Scripts Holding Co. , now in the middle of a long-term contract with health insurer Anthem Inc. , could substantially expand the number of prescriptions it manage